Nucleo

In life sciences, time matters. Deals, partnerships, insights — they shouldn’t wait for conferences or calendars. With Nucleo, you can connect, explore opportunities, and move projects forward 24/7, directly from your computer. Register for free go-nucleo.com

@o2h_discovery Great topic—moving AI from hype to real impact in drug discovery is exactly what the industry needs right now.

Next at o2h ChaiTime Hitesh Sanganee (Octopus Ventures) on “AI: From Parrot to Problem Solver”—moving AI from hype to real impact in drug discovery. Join in: luma.com/ns2b5bsu?utm_s… #o2hChaiTime #AI #drugdiscovery

@GenexploreLabs Strong program. Practical exposure in microbial analysis can really enhance both research quality and lab confidence.

🔬 3 Days Hands-on Training in Molecular Techniques for Microbial Analysis! 📅 2–4 April 2026 Upgrade your lab skills & gain practical exposure 🧪 Limited seats available — register now! 🚀 #Microbiology #MolecularBiology #Biotech #LabTraining #ScienceWorkshop #Research #SkillUp

@AnnovisBio Impressive progress. Expanding buntanetap’s potential into neurological injuries from infections could open important new therapeutic avenues.

$ANVS announces issuance of a new patent, covering buntanetap for prevention and treatment of neurological injuries from brain infections, with protection through 2044. More at annovisbio.com/press-release/… #Alzheimers #biotech #brain #infections #patent #IP

@WeAreArovella Promising approach. Combining CAR technology with iNKT cells could offer unique advantages in targeting solid tumors.

Arovella is excited to announce that it has confirmed the functionality of its novel claudin 18.2 (CLDN18.2)-targeting chimeric antigen receptor (CAR) in iNKT cells. 📽️ Dr Michael Baker explains further below: #ALA $ASX #Biotech #CellTherapy

@GanLee_ Promising work—AR PROTAC approaches could play a key role in addressing unmet needs in prostate cancer.

Gan & Lee is advancing innovative precision oncology therapies. We’re developing GLR2037, an AR PROTAC molecule, to help address unmet needs for prostate cancer patients. Turning science into patient value. #PrecisionOncology #DrugDiscovery #GanLee

@Genomeditech Nice initiative. Access to high-quality cell line models is key to generating more reliable and scalable research outcomes.

🧬 Looking to get more value out of your research this season? This April, Enjoy free shipping + exclusive discounts with every quote of Genomeditech en.genomeditech.com/cell-line #ReporterCellLines #Biotech #DrugDiscovery

@AsvinsL17651 Important focus. Consistency and market reach play a major role in successful PCD pharma distribution.

🚀 Asvins Lifecare – Powering PCD Pharma Distribution Success Grow your business with a trusted distribution partner focused on quality, consistency, and market expansion. ✅network with confidence! 📞 +91-7814620081 🌐 asvinslifecare.com #AsvinsLifecare #PCDPharma #Pharma

@legencyremedies Well said. Building trust through quality and reliability is key in supporting healthcare professionals.

Driven by care. Defined by trust. 💙 Delivering quality pharma solutions that healthcare professionals rely on. To know more, visit: legencyremedies.com #Healthcare #Pharma #TrustedCare

@Protheragen_us Fascinating work. Curious—how does EndureCART™ perform in maintaining T-cell persistence over time?

🧬 Solving Rare Cancers Precision is key. We're pairing high-affinity Bispecifics with EndureCART™ technology to boost T-cell stability and stop immune exhaustion. The future of immunotherapy is here: endurecart.protheragen.us #Biotech #Immunotherapy

@jabsbiotech Strong positioning. Bridging research and practical applications is key to driving meaningful progress in biotech.

Jabs Biotech is focused on innovation and research, turning scientific ideas into impactful biotech solutions for a healthier future. Contact us: +91 9888761706 & +91 7973383341 Email us at: jabsbiotech@gmail.com Our Website: jabsbiotech.com #Biotech #Innovation

@AnixaBio @adamsarhan Great discussion—innovative approaches to cancer treatment and prevention are always exciting to see. Looking forward to how this progresses.

Our CEO, Dr. Amit Kumar, joined Smart Money Circle with Adam Sarhan to discuss Anixa’s innovative approach to cancer treatment and prevention. Watch the full interview: youtu.be/96uSUv6CzuY Thank you @adamsarhan for the conversation. #Biotech #CancerResearch #Immunotherapy #Oncology #Innovation #Healthcare

@TeamImugene @10NewsAU Well said—translating science into therapy is a long journey. Great to see steady, step-by-step progress being made.

Turning a scientific idea into a therapy takes time. Years of testing. Validation. Refinement. Our latest data, alongside @10NewsAU coverage, shows the progress we are making step by step. youtu.be/aasEY17FQIw?si… #Imugene #Biotech #ClinicalTrials $IMU

@PeptiMatrix Strong point. Moving toward animal-free models with better control and consistency could significantly accelerate innovation while improving ethical standards.

As the UK moves toward phasing out animal testing, scientists need ethical, scalable alternatives. Animal-free hydrogels deliver: - Reproducibility - Ethical research - Better control - Faster innovation Time to rethink research tools. #Biotech #LifeSciences #EthicalScience

@xlpeptides Strong focus—purity and consistency are essential for reliable research outcomes.

XL Peptides supplies high-purity compounds for scientific research environments. Stored with care. Supplied consistently. Research use only. xlpeptides.com

@Solvonis Impressive progress. Securing composition-of-matter IP early can significantly strengthen both protection and future development pathways.

🔬 @Solvonis granted U.S. composition-of-matter patent from its #PTSD discovery programme A meaningful IP milestone — these patents protect the underlying compounds themselves, widely regarded as the strongest form of patent protection in drug development. 🧵👇

@QIAGENBiox Impressive update—expanding curated germline mutation data at this scale is a huge resource for advancing inherited disease research.

🎉 HGMD Pro 2026.1 is here! More than 4700 new mutation entries expand the largest collection of #inheriteddisease-associated, expert-curated #germline mutation data to 575,068 mutations. Check it out 👉 digitalinsights.qiagen.com/hgmd-release/?…

@StemnovateL Important approach. Integrating genomic insights with patient participation can really accelerate the development of more targeted treatments.

As a volunteer, you will receive a free genomic analysis to understand your condition better. Your participation will benefit you and contribute to the development of new treatments. Stemnovate Limited hubs.la/Q049bFzs0 #mitochondrial #rarediseases #alphersdisease #children

@KabirLife_ Important positioning. Consistent quality and regulatory standards are key to building trust in third-party manufacturing.

Kabir Lifesciences is one of ISO certified third-party manufacturing companies in India, offering high-quality pharmaceutical products. kabirlifescience.com +91 9216513000, +91 9988899414 kabirlifesciences1973@gmail.com #kabirlifesciences #PCD #pharma #franchise #pcdpharma

@GmtPharma Great to see continued focus on quality eye care solutions—manufacturing plays a key role in ensuring safe and effective products.

GMT Pharma International is a leading Eye Drops manufacturing company in India that offers effective pharma products to the market. +91-8872345222 iskonremedies7@gmail.com, iskonremedies@yahoo.com gmtpharmainternational.com #GMT #pharma #eyedrops #products #healthcareproducts